Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.02
HCA's Cash to Debt is ranked lower than
94% of the 250 Companies
in the Global Medical Care industry.

( Industry Median: 0.28 vs. HCA: 0.02 )
Ranked among companies with meaningful Cash to Debt only.
HCA' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.02 Max: N/A
Current: 0.02
Equity to Asset -0.23
HCA's Equity to Asset is ranked lower than
97% of the 248 Companies
in the Global Medical Care industry.

( Industry Median: 0.50 vs. HCA: -0.23 )
Ranked among companies with meaningful Equity to Asset only.
HCA' s Equity to Asset Range Over the Past 10 Years
Min: -0.5  Med: -0.01 Max: 0.42
Current: -0.23
-0.5
0.42
Interest Coverage 3.64
HCA's Interest Coverage is ranked lower than
74% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 7.64 vs. HCA: 3.64 )
Ranked among companies with meaningful Interest Coverage only.
HCA' s Interest Coverage Range Over the Past 10 Years
Min: 1.09  Med: 2.3 Max: 3.64
Current: 3.64
1.09
3.64
F-Score: 7
Z-Score: 2.09
M-Score: -2.92
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 14.93
HCA's Operating margin (%) is ranked higher than
76% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 7.23 vs. HCA: 14.93 )
Ranked among companies with meaningful Operating margin (%) only.
HCA' s Operating margin (%) Range Over the Past 10 Years
Min: 7.48  Med: 13.02 Max: 15.86
Current: 14.93
7.48
15.86
Net-margin (%) 6.21
HCA's Net-margin (%) is ranked higher than
59% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 4.83 vs. HCA: 6.21 )
Ranked among companies with meaningful Net-margin (%) only.
HCA' s Net-margin (%) Range Over the Past 10 Years
Min: 2.37  Med: 4.43 Max: 8.3
Current: 6.21
2.37
8.3
ROA (%) 7.79
HCA's ROA (%) is ranked higher than
71% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 4.14 vs. HCA: 7.79 )
Ranked among companies with meaningful ROA (%) only.
HCA' s ROA (%) Range Over the Past 10 Years
Min: 2.79  Med: 5.25 Max: 9.71
Current: 7.79
2.79
9.71
ROC (Joel Greenblatt) (%) 32.23
HCA's ROC (Joel Greenblatt) (%) is ranked higher than
66% of the 252 Companies
in the Global Medical Care industry.

( Industry Median: 19.67 vs. HCA: 32.23 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HCA' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 19.55  Med: 30.17 Max: 37.66
Current: 32.23
19.55
37.66
Revenue Growth (3Y)(%) 9.00
HCA's Revenue Growth (3Y)(%) is ranked higher than
54% of the 180 Companies
in the Global Medical Care industry.

( Industry Median: 8.40 vs. HCA: 9.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HCA' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -7.8  Med: 8.2 Max: 24.3
Current: 9
-7.8
24.3
EBITDA Growth (3Y)(%) 8.30
HCA's EBITDA Growth (3Y)(%) is ranked higher than
56% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 7.30 vs. HCA: 8.30 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
HCA' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -10  Med: 8.2 Max: 39.4
Current: 8.3
-10
39.4
EPS Growth (3Y)(%) 12.70
HCA's EPS Growth (3Y)(%) is ranked higher than
61% of the 132 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. HCA: 12.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HCA' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 6.9 Max: 88.4
Current: 12.7
0
88.4
GuruFocus has detected 2 Warning Signs with HCA Holdings Inc $HCA.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» HCA's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

HCA Guru Trades in Q4 2015

First Pacific Advisors 49,770 sh (New)
George Soros 79,247 sh (New)
Joel Greenblatt 247,339 sh (New)
Louis Moore Bacon 130,000 sh (New)
Steven Cohen 109,300 sh (New)
Richard Perry 3,063,000 sh (New)
Larry Robbins 14,300,549 sh (+159.38%)
David Tepper 4,537,063 sh (+27.68%)
Paul Tudor Jones 9,619 sh (+23.32%)
Vanguard Health Care Fund 11,911,153 sh (+16.96%)
Mario Gabelli 27,800 sh (+2.11%)
Samuel Isaly 1,220,500 sh (unchged)
Pioneer Investments Sold Out
John Paulson Sold Out
John Hussman Sold Out
David Dreman 22,684 sh (-12.08%)
Jim Simons 262,500 sh (-49.17%)
» More
Q1 2016

HCA Guru Trades in Q1 2016

Lee Ainslie 369,220 sh (New)
Pioneer Investments 90,037 sh (New)
Jeremy Grantham 5,500 sh (New)
Joel Greenblatt 622,232 sh (+151.57%)
Steven Cohen 247,800 sh (+126.72%)
Mario Gabelli 50,400 sh (+81.29%)
David Dreman 25,171 sh (+10.96%)
Larry Robbins 14,675,592 sh (+2.62%)
George Soros Sold Out
Jim Simons Sold Out
Louis Moore Bacon Sold Out
Paul Tudor Jones Sold Out
First Pacific Advisors Sold Out
Vanguard Health Care Fund 11,682,053 sh (-1.92%)
Richard Perry 2,768,000 sh (-9.63%)
David Tepper 3,173,423 sh (-30.06%)
Samuel Isaly 1,107,100 sh (-9.29%)
» More
Q2 2016

HCA Guru Trades in Q2 2016

John Hussman 100,000 sh (New)
Paul Tudor Jones 22,420 sh (New)
Andreas Halvorsen 1,089,482 sh (New)
Jim Simons 574,500 sh (New)
Joel Greenblatt 916,670 sh (+47.32%)
Pioneer Investments 90,948 sh (+1.01%)
Vanguard Health Care Fund 11,682,053 sh (unchged)
Mario Gabelli 50,400 sh (unchged)
Lee Ainslie Sold Out
Steven Cohen Sold Out
Richard Perry Sold Out
David Dreman 25,075 sh (-0.38%)
Larry Robbins 14,586,992 sh (-0.60%)
Jeremy Grantham 3,900 sh (-29.09%)
David Tepper 1,216,940 sh (-61.65%)
Samuel Isaly 709,300 sh (-35.93%)
» More
Q3 2016

HCA Guru Trades in Q3 2016

Glenn Greenberg 2,498,550 sh (New)
John Paulson 162,500 sh (New)
Steve Mandel 1,669,543 sh (New)
Jeremy Grantham 4,400 sh (+12.82%)
Larry Robbins 15,988,990 sh (+9.61%)
David Tepper 1,236,940 sh (+1.64%)
Mario Gabelli 50,400 sh (unchged)
Vanguard Health Care Fund 11,682,053 sh (unchged)
Paul Tudor Jones Sold Out
Andreas Halvorsen Sold Out
Pioneer Investments Sold Out
John Hussman Sold Out
David Dreman 24,263 sh (-3.24%)
Joel Greenblatt 379,392 sh (-58.61%)
Jim Simons 45,100 sh (-92.15%)
Samuel Isaly 304,824 sh (-57.02%)
» More
» Details

Insider Trades

Latest Guru Trades with HCA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 622110    SIC: 8062
Compare:NYSE:FMS, OTCPK:FSNUY, NYSE:DVA, NYSE:UHS, OTCPK:BDULF, NYSE:EVHC, NYSE:MD, OTCPK:SKHCF, NAS:WOOF, OTCPK:CAKFY, NYSE:HLS, OTCPK:NMHLY, NAS:ACHC, NYSE:CHE, OTCPK:LTGHY, NAS:LPNT, NAS:SCAI, NYSE:SEM, NYSE:AMN, NYSE:THC » details
Traded in other countries:2BH.Germany,
HCA Holdings Inc is a health care services company. It operates general acute care hospitals, psychiatric hospitals; and rehabilitation hospitals. It also operates freestanding surgery centers.

HCA Holdings Inc was incorporated in Nevada in January 1990 and reincorporated in Delaware in September 1993. It is a health care services company in the United States. It operates 168 hospitals, comprised of 164 general, acute care hospitals; three psychiatric hospitals; and one rehabilitation hospital. In addition, it operates 116 freestanding surgery centers. Its facilities are located in 20 states and England. Its general, acute care hospitals typically provide services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Outpatient and ancillary health care services are provided by its general, acute care hospitals, freestanding surgery centers, diagnostic centers and rehabilitation facilities. Its psychiatric hospitals provide mental health care services through inpatient, partial hospitalization and outpatient settings. The Company is subject to various federal, state and local statutes and ordinances regulating the discharge of materials into the environment. Some competing facilities are physician-owned or are owned by tax-supported government agencies and many others are owned by not-for-profit entities that may be supported by endowments, charitable contributions and/or tax revenues and are exempt from sales, property and income taxes. It also faces competition from specialty hospitals and from both its own and unaffiliated freestanding ASCs for market share in certain high margin services.

Guru Investment Theses on HCA Holdings Inc

Bill Nygren Comments on HCA - Jan 10, 2017

HCA (NYSE:HCA) is the largest operator of for-profit hospitals and related health care services in the U.S. The company benefits from scale and size advantages, an attractive geographic footprint in higher growth markets, best-in-class management and governance, and an equity-friendly approach to capital allocation. We expect HCA to grow operating income in the mid-single digits and grow EPS in the low-double digits over time. Hospital stocks sold off following the presidential election due to concerns that the benefits from health care reform will be lost. We believe that HCA’s share price discounts the effects of repealing the Affordable Care Act. Accordingly, the shares are selling below our estimate of intrinsic value.

From Bill Nygren (Trades, Portfolio)'s Oakmark Fund fourth quarter 2016 commentary.

Check out Bill Nygren latest stock trades

Top Ranked Articles about HCA Holdings Inc

Bill Nygren Comments on HCA Guru stock highlight
HCA (NYSE:HCA) is the largest operator of for-profit hospitals and related health care services in the U.S. The company benefits from scale and size advantages, an attractive geographic footprint in higher growth markets, best-in-class management and governance, and an equity-friendly approach to capital allocation. We expect HCA to grow operating income in the mid-single digits and grow EPS in the low-double digits over time. Hospital stocks sold off following the presidential election due to concerns that the benefits from health care reform will be lost. We believe that HCA’s share price discounts the effects of repealing the Affordable Care Act. Accordingly, the shares are selling below our estimate of intrinsic value. Read more...
Glenn Greenberg Gains 3 Positions in the 3rd Quarter Guru invests in health care, technology and telecommunications
Brave Warrior Advisors’ Glenn Greenberg (Trades, Portfolio) purchased three new holdings in the third quarter. They are HCA Holdings Inc. (NYSE:HCA), Sensata Technologies Holding NV (NYSE:ST) and LiLAC Group (NASDAQ:LILAK). Read more...
David Tepper Exits Facebook, Boosts Allergan Guru's second quarter trades
David Tepper (Trades, Portfolio) is the founder of Appaloosa Management, which is a $3 billion hedge fund investment firm based in Chatham, New Jersey. The following are his largest trades of the second quarter. Read more...
Richard Perry Sells HCA Holdings, AIG Guru's largest 2nd quarter trades
Richard Perry (Trades, Portfolio) co-founded private investment management firm Perry Capital LLC in 1988, which manages about $14 billion as of August 2008. During the second quarter, the company traded the following stocks. Read more...
John Hussman Buys Infosys, Southern The guru's largest 2nd-quarter acquisitions
John Hussman (Trades, Portfolio) is the president and principal shareholder of Hussman Strategic Advisors, the investment advisory firm that manages the Hussman Funds. During the second quarter he bought shares in the following stocks. Read more...
Richard Perry Trims Time Warner, AIG The guru's largest 1st-quarter transactions
Richard Perry (Trades, Portfolio) co-founded private investment management firm Perry Capital LLC in 1988, which manages about $14 billion as of August 2008. The following are his largest deals during the first quarter: Read more...
All-In-One Screener Finds Week's Largest Insider Trades A recap of the most important transactions
The All-in-One Screener can be used to find insider buys and sells over the last week by clicking on the Insiders tab and changing the settings for All Insider Buying to “$1,000,000+” and duration to "May 2016.” Read more...
John Paulson Trims Stake in Allergan, Time Warner Cable Event-driven investor's top 4th quarter trades
John Paulson (Trades, Portfolio) established Paulson & Co. Inc. as a merger arbitrage hedge fund manager, seeking to make money from situations when one public company announces plans to take over another. During the fourth quarter, he sold many stocks including the following. Read more...
John Paulson Sells Allergan, Precision Castparts, AIG Top sales by the investor during the 4th quarter
John Paulson (Trades, Portfolio) is the president and portfolio manager of Paulson & Co. Inc. Paulson was ranked by Absolute Return Magazine as the third-largest hedge fund in the world managing approximately $29 billion in merger, event and distressed strategies. The following are the guru's largest sales during the fourth quarter of 2015. Read more...
Richard Perry Invests in 3 Energy Stocks in 4th Quarter Investment in health care company was guru's largest transaction
Richard Perry (Trades, Portfolio), co-founder of Perry Capital LLC, purchased four new stakes in the fourth quarter, three of which are in energy-related companies. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 12.58
HCA's P/E(ttm) is ranked higher than
88% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 26.17 vs. HCA: 12.58 )
Ranked among companies with meaningful P/E(ttm) only.
HCA' s P/E(ttm) Range Over the Past 10 Years
Min: 4.08  Med: 13.68 Max: 19.67
Current: 12.58
4.08
19.67
Forward P/E 11.17
HCA's Forward P/E is ranked higher than
88% of the 66 Companies
in the Global Medical Care industry.

( Industry Median: 18.90 vs. HCA: 11.17 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 12.58
HCA's PE(NRI) is ranked higher than
89% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 26.51 vs. HCA: 12.58 )
Ranked among companies with meaningful PE(NRI) only.
HCA' s PE(NRI) Range Over the Past 10 Years
Min: 4.08  Med: 13.68 Max: 19.67
Current: 12.58
4.08
19.67
Price/Owner Earnings (ttm) 10.30
HCA's Price/Owner Earnings (ttm) is ranked higher than
86% of the 91 Companies
in the Global Medical Care industry.

( Industry Median: 26.85 vs. HCA: 10.30 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
HCA' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 6.27  Med: 12.09 Max: 58.95
Current: 10.3
6.27
58.95
P/S 0.81
HCA's P/S is ranked higher than
75% of the 237 Companies
in the Global Medical Care industry.

( Industry Median: 1.45 vs. HCA: 0.81 )
Ranked among companies with meaningful P/S only.
HCA' s P/S Range Over the Past 10 Years
Min: 0.32  Med: 0.66 Max: 1.07
Current: 0.81
0.32
1.07
PFCF 11.49
HCA's PFCF is ranked higher than
87% of the 105 Companies
in the Global Medical Care industry.

( Industry Median: 23.25 vs. HCA: 11.49 )
Ranked among companies with meaningful PFCF only.
HCA' s PFCF Range Over the Past 10 Years
Min: 4.19  Med: 11.47 Max: 17.22
Current: 11.49
4.19
17.22
POCF 5.89
HCA's POCF is ranked higher than
90% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 14.44 vs. HCA: 5.89 )
Ranked among companies with meaningful POCF only.
HCA' s POCF Range Over the Past 10 Years
Min: 2.58  Med: 5.68 Max: 8.53
Current: 5.89
2.58
8.53
EV-to-EBIT 10.24
HCA's EV-to-EBIT is ranked higher than
91% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 20.40 vs. HCA: 10.24 )
Ranked among companies with meaningful EV-to-EBIT only.
HCA' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.3  Med: 10.7 Max: 12.6
Current: 10.24
6.3
12.6
EV-to-EBITDA 7.76
HCA's EV-to-EBITDA is ranked higher than
87% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 14.49 vs. HCA: 7.76 )
Ranked among companies with meaningful EV-to-EBITDA only.
HCA' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5  Med: 7.9 Max: 9.4
Current: 7.76
5
9.4
PEG 2.42
HCA's PEG is ranked higher than
56% of the 82 Companies
in the Global Medical Care industry.

( Industry Median: 2.76 vs. HCA: 2.42 )
Ranked among companies with meaningful PEG only.
HCA' s PEG Range Over the Past 10 Years
Min: 0.74  Med: 2.38 Max: 6.45
Current: 2.42
0.74
6.45
Shiller P/E 17.52
HCA's Shiller P/E is ranked higher than
78% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 28.63 vs. HCA: 17.52 )
Ranked among companies with meaningful Shiller P/E only.
HCA' s Shiller P/E Range Over the Past 10 Years
Min: 6.14  Med: 12.95 Max: 22.97
Current: 17.52
6.14
22.97
Current Ratio 1.72
HCA's Current Ratio is ranked higher than
65% of the 252 Companies
in the Global Medical Care industry.

( Industry Median: 1.27 vs. HCA: 1.72 )
Ranked among companies with meaningful Current Ratio only.
HCA' s Current Ratio Range Over the Past 10 Years
Min: 0.81  Med: 1.51 Max: 1.9
Current: 1.72
0.81
1.9
Quick Ratio 1.42
HCA's Quick Ratio is ranked higher than
60% of the 252 Companies
in the Global Medical Care industry.

( Industry Median: 1.14 vs. HCA: 1.42 )
Ranked among companies with meaningful Quick Ratio only.
HCA' s Quick Ratio Range Over the Past 10 Years
Min: 0.71  Med: 1.33 Max: 1.68
Current: 1.42
0.71
1.68
Days Inventory 77.28
HCA's Days Inventory is ranked lower than
87% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 17.58 vs. HCA: 77.28 )
Ranked among companies with meaningful Days Inventory only.
HCA' s Days Inventory Range Over the Past 10 Years
Min: 54.26  Med: 65.41 Max: 77.28
Current: 77.28
54.26
77.28
Days Sales Outstanding 48.87
HCA's Days Sales Outstanding is ranked lower than
60% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 42.10 vs. HCA: 48.87 )
Ranked among companies with meaningful Days Sales Outstanding only.
HCA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.84  Med: 53.01 Max: 56.3
Current: 48.87
44.84
56.3
Days Payable 104.41
HCA's Days Payable is ranked higher than
76% of the 160 Companies
in the Global Medical Care industry.

( Industry Median: 38.65 vs. HCA: 104.41 )
Ranked among companies with meaningful Days Payable only.
HCA' s Days Payable Range Over the Past 10 Years
Min: 104.41  Med: 112.98 Max: 119.5
Current: 104.41
104.41
119.5

Buy Back

vs
industry
vs
history
Yield on cost (5-Year) 0.30
HCA's Yield on cost (5-Year) is ranked lower than
96% of the 305 Companies
in the Global Medical Care industry.

( Industry Median: 2.26 vs. HCA: 0.30 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
HCA' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 0.3
3-Year Average Share Buyback Ratio 3.50
HCA's 3-Year Average Share Buyback Ratio is ranked higher than
95% of the 125 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. HCA: 3.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HCA' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -4.1  Med: 2.9 Max: 12
Current: 3.5
-4.1
12

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.51
HCA's Price/Projected FCF is ranked higher than
61% of the 99 Companies
in the Global Medical Care industry.

( Industry Median: 1.72 vs. HCA: 1.51 )
Ranked among companies with meaningful Price/Projected FCF only.
HCA' s Price/Projected FCF Range Over the Past 10 Years
Min: 1.43  Med: 3.8 Max: 17.85
Current: 1.51
1.43
17.85
Price/DCF (Earnings Based) 1.18
HCA's Price/DCF (Earnings Based) is ranked higher than
79% of the 29 Companies
in the Global Medical Care industry.

( Industry Median: 1.65 vs. HCA: 1.18 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.19
HCA's Price/Median PS Value is ranked lower than
64% of the 207 Companies
in the Global Medical Care industry.

( Industry Median: 1.02 vs. HCA: 1.19 )
Ranked among companies with meaningful Price/Median PS Value only.
HCA' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.54  Med: 0.98 Max: 1.57
Current: 1.19
0.54
1.57
Price/Peter Lynch Fair Value 1.80
HCA's Price/Peter Lynch Fair Value is ranked higher than
57% of the 46 Companies
in the Global Medical Care industry.

( Industry Median: 2.34 vs. HCA: 1.80 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
HCA' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.84  Med: 2.08 Max: 3.67
Current: 1.8
0.84
3.67
Earnings Yield (Greenblatt) (%) 9.79
HCA's Earnings Yield (Greenblatt) (%) is ranked higher than
94% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 3.80 vs. HCA: 9.79 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HCA' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 8  Med: 9.3 Max: 16
Current: 9.79
8
16
Forward Rate of Return (Yacktman) (%) 13.51
HCA's Forward Rate of Return (Yacktman) (%) is ranked higher than
64% of the 114 Companies
in the Global Medical Care industry.

( Industry Median: 9.76 vs. HCA: 13.51 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
HCA' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 9  Med: 13.3 Max: 17.6
Current: 13.51
9
17.6

More Statistics

Revenue (TTM) (Mil) $41,098
EPS (TTM) $ 6.32
Short Percentage of Float4.18%
52-Week Range $60.07 - 83.69
Shares Outstanding (Mil)374.69

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 43,148 45,358 47,966
EPS ($) 6.55 7.01 7.84
EPS w/o NRI ($) 6.55 7.01 7.84
EPS Growth Rate
(3Y to 5Y Estimate)
11.95%
Dividends Per Share ($)
» More Articles for HCA

Headlines

Articles On GuruFocus.com
Bill Nygren Comments on HCA Jan 10 2017 
Michael Burry and HCA Holdings Dec 16 2016 
Michael Burry: Current Holdings and a Change of Style Dec 09 2016 
Glenn Greenberg Gains 3 Positions in the 3rd Quarter Dec 05 2016 
Dr. Michael Burry of 'The Big Short' Buys Coty and Further Slims Portfolio Dec 01 2016 
Can Universal Health Services Power Past the Political Turbulence? Nov 30 2016 
What to Buy Now That Donald Trump Is President-elect Nov 11 2016 
David Tepper Exits Facebook, Boosts Allergan Aug 31 2016 
The Big 3: Larry Robbins' Top 2nd-Quarter Buys Aug 16 2016 
John Hussman Buys Infosys, Southern Aug 12 2016 

More From Other Websites
HCA 4th Quarter 2016 Earnings Conference Call Jan 17 2017
Missouri appeals court cuts $434M judgment against HCA by more than half Jan 17 2017
Can HCA Holdings (HCA) Be a Top Choice for Value Investors? Jan 17 2017
HCA upgraded by Avondale Jan 17 2017
Quest Diagnostics (DGX) Q4 Earnings: What Lies in Store? Jan 16 2017
Can HCA Holdings Retain its Business Strength in 2017? Jan 12 2017
Bill Nygren Comments on HCA Jan 10 2017
Bill Nygren's Oakmark Fund Commentary: Fourth Quarter 2016 Jan 10 2017
Should Value Investors Consider HCA Holdings Stock? Jan 09 2017
HCA HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jan 09 2017
HCA Previews 2016 Operating Results Jan 09 2017
Obama's 'Last' Jobs Report Trails Estimates -- and Doesn't Help Trump Either Jan 06 2017
Ready for round two: HCA's TriStar renews fight for Brentwood ER project Jan 03 2017
HCA Holdings Holds Promise Despite Headwinds: Here's Why Dec 30 2016
HCA to Present at January Healthcare Conferences Dec 28 2016
Top Ranked Growth Stocks to Buy for December 28th Dec 28 2016
Quest Diagnostics: Strong Q3, Strategic Initiatives Add Value Dec 28 2016
Healthcare Stocks Tenet Healthcare and HCA Holdings Inc. Facing Pressure Following Trumps Election Dec 22 2016
Tenet, HCA Among Potential Health Care Losers in 2017, Says S&P Capital IQ Dec 19 2016
Michael Burry and HCA Holdings Dec 16 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)